|
Volumn 17, Issue 4 SUPPL., 2003, Pages
|
Alemtuzumab induction and steroid avoidance in kidney and pancreas transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
RAPAMYCIN;
STEROID;
TACROLIMUS;
ACUTE KIDNEY TUBULE NECROSIS;
B LYMPHOCYTE;
BACTERIAL INFECTION;
CEREBROVASCULAR ACCIDENT;
CHRONIC LYMPHATIC LEUKEMIA;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMOLYTIC UREMIC SYNDROME;
HERPES VIRUS INFECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
LONG TERM CARE;
LOW DRUG DOSE;
LUNG EMBOLISM;
MAINTENANCE THERAPY;
MOUTH INFECTION;
NEPHROTOXICITY;
NOTE;
PANCREAS TRANSPLANTATION;
PATIENT COMPLIANCE;
RECIPIENT;
RECURRENT DISEASE;
RISK ASSESSMENT;
SIDE EFFECT;
SURVIVAL RATE;
T LYMPHOCYTE;
TREATMENT OUTCOME;
VIRUS ENCEPHALITIS;
|
EID: 0344237265
PISSN: 0955470X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trre.2003.07.005 Document Type: Article |
Times cited : (2)
|
References (0)
|